Y-mAbs(US:YMAB) ZACKSยท2025-09-01 14:56Group 1 - Y-mAbs Therapeutics, Inc. (YMAB) has reached an important support level and recently experienced a "golden cross," indicating a potential bullish breakout [1][2] - A golden cross occurs when a short-term moving average, such as the 50-day, crosses above a longer-term moving average, like the 200-day, suggesting stronger breakout potential [2][3] - YMAB has rallied 88.7% over the past four weeks and currently holds a 2 (Buy) rating on the Zacks Rank, indicating a strong potential for further gains [4][6] Group 2 - The positive earnings outlook for YMAB is supported by no earnings estimate cuts and two upward revisions in the past 60 days, with the Zacks Consensus Estimate also increasing [4] - Investors are encouraged to monitor YMAB for additional gains due to its key technical level and favorable earnings estimate revisions [6]